Changes in guidelines on named patient programmesDicle Doğan and Merve Çimen, Gun + Partners
On 29 March 2017, the Turkish Medicines and Medical Devices Agency amended the Guidelines on the Supply from Abroad and the Use of Pharmaceuticals. The amended guidelines establish a new practice in the Named Patient Programme (NPP) that enables the Social Security Institution to import non-approved or unavailable pharmaceutical products from abroad on a named patient basis. The forme...
This event has passed.
Gün + Partners is joining the 5th Invest in Turkey Forum 2017 in London on 28 April 2017.
Ozan Karaduman, Managing Associate, is the panellist in “The Energy Industry in Turkey – The Most Important Questions?” session.
Topics for discussion include:
Turkish energy strategies: Where is Turkey headed?
What projects are expected to be announced over the next 12 months?
What changes are being made to regulatory / legislative framework to determine more i...